Rassoul Dinarvand - Nanotechnology

Author Information

Rassoul Dinarvand is affiliated with the Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. His research primarily focuses on the development and application of nanotechnology in medical sciences.

Research Contributions

Rassoul Dinarvand has made significant contributions to the field of nanotechnology, particularly in the development of novel nanomaterials for drug delivery and biomedical applications. In 2022, he has published works on various topics including self-assembled nanogels, pH-responsive nanoniosomes for breast cancer treatment, biodistribution of nanoparticles in retinoblastoma, hybrid metal-organic frameworks for SARS-CoV-2 detection, and ocular delivery of natural compounds. His research in 2021 includes the development of nanoparticles for prostate cancer treatment, self-healable conductive polyurethane for bone tissue engineering, and safe nanocarriers for drug and gene delivery. These contributions underscore his expertise in creating innovative solutions for complex medical challenges using nanotechnology.

Aliases

Rassoul Dinarvand is also known by the following aliases: R Dinarvand, R. Dinarvand.

Publication and Citation Metrics

Metric	Value
Citation Count	13560
h-index	59
Paper Count	469

Publications:

Novel self- assembled nanogels of PEG-grafted poly HPMA with bis(α-cyclodextrin) containing disulfide linkage: synthesis, bio-disintegration, and in vivo biocompatibility

DOI: 10.1039/d1nj05974b

Year: 2022

pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

DOI: 10.1021/acsabm.1c01107

Year: 2022

Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma

DOI: 10.18502/jovr.v17i1.10171

Year: 2022

Bioactive hybrid metal-organic framework (MOF)-based nanosensors for optical detection of recombinant SARS-CoV-2 spike antigen

DOI: 10.1016/j.scitotenv.2022.153902

Year: 2022

Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds

DOI: 10.3389/fchem.2022.850757

Year: 2022

Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers

DOI: 10.34172/bi.2021.23389

Year: 2022

Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel

DOI: 10.1080/10837450.2021.1875238

Year: 2021

Self-healable conductive polyurethane with the body temperature‐responsive shape memory for bone tissue engineering

DOI: 10.1016/J.CEJ.2021.128449

Year: 2021

Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR.

DOI: 10.1021/ACSABM.1C00447

Year: 2021

Polymer-Coated NH2-UiO-66 for the Codelivery of DOX/pCRISPR.

DOI: 10.1021/acsami.1c01460

Year: 2021

How Does Citrate Buffer Stabilize Nanoparticles?

What are the Properties of Silver Nanoparticles?

Why is Reduced Photobleaching Important?

What Factors Influence Auger Recombination in Nanomaterials?

What is Green Hydrogen?

What Role Do International Standards Play?

What is Material Absorption in Nanotechnology?

What are the recent advancements in Nanotechnology?

What are Spintronic Devices?

What is Amber?

Partnered Content Networks

Relevant Topics